Monday, May 28, 2018

Macquarie upgraded Sun Pharma to ‘Neutral’ from ‘Underperform’ with a target price of Rs 460.

from Stocks-Markets-The Economic Times https://ift.tt/2kwdZyo

Related Posts:

  • LATEST STOCK MARKET NEWSCentre has given nod to prosecute 5 people, including Chawla, accused in Aircel-Maxis case. from Stocks-Markets-Economic Times http://bit.ly/2snW1C4 … Read More
  • LATEST STOCK MARKET NEWSMarket has not been able to take a directional cue overall from the global markets. from Stocks-Markets-Economic Times http://bit.ly/2M6FPy3 … Read More
  • LATEST STOCK MARKET NEWSThe company said it will raise funds in three tranches. from Stocks-Markets-Economic Times http://bit.ly/2RjNxus … Read More
  • LATEST STOCK MARKET NEWSInfosys posted 29.62 per cent year-on-year (YoY) drop in Q3 profit at Rs 3,610 crore. from Stocks-Markets-Economic Times http://bit.ly/2H7kkhQ … Read More
  • LATEST STOCK MARKET NEWSBidding for the bond issue opened Friday and it received an overwhelming response. from Stocks-Markets-Economic Times http://bit.ly/2CegNIS … Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner